Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Third Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer: Summary of the results of a questionnaire survey of oncologists and diabetologists-Secondary publication.
Goto A, Ohashi K, Noda M, Noto H, Ueki K, Inoue M, Nishimura R, Takahashi S, Ioka T, Oshima M, Fujibayashi K, Tsuji A, Kodaira M, Tamakoshi A, Mimori K, Tanabe Y, Hara E, Matsuo K, Murakami Y, Watada H. Goto A, et al. Among authors: nishimura r. Cancer Sci. 2024 Feb;115(2):672-681. doi: 10.1111/cas.15975. Epub 2024 Jan 7. Cancer Sci. 2024. PMID: 38184804 Free PMC article.
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Ueki K, et al. Among authors: nishimura r. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787. BMJ Open Diabetes Res Care. 2021. PMID: 33441417 Free PMC article.
Dietary intake and physical activity in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 8).
Horikawa C, Tsuda K, Oshida Y, Satoh J, Hayashino Y, Tajima N, Nishimura R, Sone H; JDCP Study Group. Horikawa C, et al. Among authors: nishimura r. Diabetol Int. 2022 Mar 24;13(2):344-357. doi: 10.1007/s13340-022-00575-0. eCollection 2022 Apr. Diabetol Int. 2022. PMID: 35463859 Free PMC article.
Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists-secondary publication.
Goto A, Ohashi K, Noda M, Noto H, Ueki K, Inoue M, Nishimura R, Takahashi S, Ioka T, Oshima M, Fujibayashi K, Tsuji A, Kodaira M, Tamakoshi A, Mimori K, Tanabe Y, Hara E, Matsuo K, Murakami Y, Watada H. Goto A, et al. Among authors: nishimura r. Diabetol Int. 2024 Jan 8;15(1):5-18. doi: 10.1007/s13340-023-00672-8. eCollection 2024 Jan. Diabetol Int. 2024. PMID: 38264218 Free PMC article.
Guidelines for clinical evaluation of chronic kidney disease in early stages : AMED research on regulatory science of pharmaceuticals and medical devices.
Sugawara Y, Kanda E, Hamano T, Itano S, Okada H, Tomori K, Watanabe Y, Asakura W, Isaka Y, Iseki K, Usui T, Suzuki Y, Tanaka M, Nishimura R, Fukami K, Matsushita K, Wada J, Watada H, Ueki K, Kashihara N, Nangaku M; Research Working Group for Establishing Guidelines for Clinical Evaluation of Chronic Kidney Disease. Sugawara Y, et al. Among authors: nishimura r. Clin Exp Nephrol. 2024 Sep;28(9):847-865. doi: 10.1007/s10157-024-02514-6. Epub 2024 Jul 6. Clin Exp Nephrol. 2024. PMID: 38970650 Free PMC article.
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version).
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, Yabe D, Nishimura R, Harada N, Kamiya H, Suzuki R, Yamauchi T; JDS Committee on Consensus Statement Development. Bouchi R, et al. Among authors: nishimura r. J Diabetes Investig. 2024 Sep;15(9):1326-1342. doi: 10.1111/jdi.14202. Epub 2024 Jul 11. J Diabetes Investig. 2024. PMID: 38988282 Free PMC article.
Efficacy and safety of once-weekly insulin icodec versus once-daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials.
Watada H, Ásbjörnsdóttir B, Nishida T, Nishimura R, Yamamoto Y, Yamauchi T, Kadowaki T. Watada H, et al. Among authors: nishimura r. Diabetes Obes Metab. 2024 Dec;26(12):5882-5895. doi: 10.1111/dom.15960. Epub 2024 Sep 30. Diabetes Obes Metab. 2024. PMID: 39344833 Clinical Trial.
Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3).
Hayashino Y, Izumi K, Okamura S, Nishimura R, Origasa H, Tajima N; JDCP study group. Hayashino Y, et al. Among authors: nishimura r. J Diabetes Investig. 2017 Mar;8(2):243-249. doi: 10.1111/jdi.12550. Epub 2016 Aug 10. J Diabetes Investig. 2017. PMID: 27390272 Free PMC article.
The current status of treatment-related severe hypoglycemia in Japanese patients with diabetes mellitus: A report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society.
Namba M, Iwakura T, Nishimura R, Akazawa K, Matsuhisa M, Atsumi Y, Satoh J, Yamauchi T; Japan Diabetes Society (JDS) Committee for Surveys on Severe Hypoglycemia. Namba M, et al. Among authors: nishimura r. J Diabetes Investig. 2018 Mar 2;9(3):642-56. doi: 10.1111/jdi.12790. Online ahead of print. J Diabetes Investig. 2018. PMID: 29498232 Free PMC article.
2,138 results